اسأل أو ابحث عن أي شيء...
Hot Research Today
Papers from every journal, all in one place. أنشئ موجزات مخصصة.
1w ago
Expert CommentaryCirculation Highlight
Level 1: Clinical Guideline
Strategies for Optimizing Heart Failure Care in the Older Adult: A Scientific Statement From the American Heart Association
Implication
Tailored plans needed to improve GDMT access in older HF patients; extends recommendations to address age-specific barriers.
Circulation
1w agoOpen Access
Expert CommentaryACC Journal Scan Highlight
Level 2: RCT
Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy
Aficamten monotherapy improves submaximal exercise VE/VCO2 slope by ~2.8 points vs metoprolol in symptomatic oHCM.
Implication
Aficamten may be preferred over metoprolol for exercise capacity in symptomatic obstructive HCM; extends RCT evidence for myosin inhibitors versus beta-blockade.
““These findings provide compelling justification for aficamten treatment as an appropriate alternative to current first-line treatment with metoprolol, to treat exercise intolerance in oHCM.””
— ACC Journal ScanView source
JAMA Cardiology
Harvard University
3w agoOpen Access
Featured in PodcastExpert CommentaryACC Journal Scan Highlight
Level 2: RCT
10-Year Randomized Outcomes of Transcatheter or Surgical Aortic Valve Replacement in Intermediate-Risk Aortic Stenosis
TAVR with SAPIEN XT increases 10-year all-cause mortality ~13% versus surgery.
Implication
May favor surgery over early-generation TAVR for 10-year survival in intermediate-risk patients; challenges assumptions of long-term equivalence.
“Taken together, the studies show a likely early advantage of TAVR with respect to the important primary clinical endpoints, with a later catch-up of surgery, such that there are no major differences between the therapies at 5 years.”
— Dr. Tamim NazifView source
Journal of the American College of Cardiology
Stanford University
4w ago
Expert CommentaryCirculation Highlight
Level 2: RCT
Pulsed Field Ablation Versus Sham to Treat Atrial Fibrillation: The PFA-SHAM Randomized Clinical Trial
Pulsed field ablation cuts 6-month atrial tachyarrhythmia recurrence by ~92% versus sham.
Implication
PFA markedly outperforms sham for AF recurrence and QoL; confirms ablation benefit beyond placebo in symptomatic patients.
“It provides strong evidence of efficacy of the active treatment and evidence against it just being a placebo effect. And it treats both the doctor and the patient. It treats us by reducing the detected amount of atrial fibrillation that we see with, importantly, a loop recorder in all of these patients. And also it treats the patient because there was subjective improvement in the AFEQT score and the HADS score.”
— Daniel MorinView source
Circulation
Charles University
3w ago
Expert CommentaryCirculation Highlight
Level 1: Clinical Guideline
Role of Physical Activity in Obesity Treatment and Cardiometabolic Health: A Scientific Statement From the American Heart Association
Implication
Prescribe physical activity for cardiometabolic gains irrespective of weight loss; extends evidence for multimodal obesity management.
Circulation
2w ago
Expert CommentaryFeatured in PodcastCirculation Highlight
Level 1: Clinical Guideline
Use of Predicted Risk and Expected Benefit to Guide Decision-Making in Cardiovascular-Kidney-Metabolic Syndrome for the Primary Prevention of Cardiovascular Disease: A Scientific Statement From the American Heart Association and American College of Cardiology
Implication
Scientific statement examines risk assessment for improving cardiovascular disease prevention strategies.
Circulation
2d agoOpen Access
Circulation Highlight
Level 1: Clinical Guideline
Heart Failure Occurring in the Perinatal Period: A Scientific Statement From the American Heart Association
Implication
May inform perinatal HF care via expert consensus; leaves open standardized definitions and screening tools.
Circulation
1w ago
Circulation Highlight
Level 1: Clinical Guideline
Defining Cardiovascular Endpoints in Oncology Trials: Challenges and Opportunities: A Scientific Statement From the American Heart Association
Implication
May enhance CV endpoint consistency in oncology trials; leaves open effects on outcomes or regulatory decisions pending validation.
Circulation
3w ago
Trending on XExpert CommentaryACC Journal Scan Highlight
Level 3: Cohort Study
Resistance Training, Aerobic Activity, Television Viewing, and Risk of Major Cardiovascular Events in U.S. Women
Resistance training ≥2 hours weekly in women linked to ~20% lower major CVD risk.
Implication
Observational data should not yet change practice; extends evidence on resistance training for CVD prevention in women but requires trials.
“These findings suggest that, within an already active population, RT is associated with additional reductions in [cardiovascular disease] risk above and beyond overall aerobic activity. Alongside aerobic activity and reductions in sedentary behavior, RT may be an important component of public hea...”
— ACC Journal ScanView source
Journal of the American College of Cardiology
Harvard University
3w agoOpen Access
Expert CommentaryCirculation Highlight
Level 3: Cohort Study
Lifestyle-Induced Visceral Fat Loss as a Key Target for Durable Cardiometabolic Health: MRI-Assessed 5- and 10-Year Follow-Up After 2 Clinical Trials
Intervention-induced visceral fat loss linked to ~28% lower incident T2D risk per ten percent reduction.
Implication
Visceral fat loss may inform diabetes prevention targets; hypothesis-generating and requires randomized confirmation.
“Repeated participation in a lifestyle program for weight loss, even after a perceived 'failure,' may lead to significant health benefits over the years, especially in reducing dangerous abdominal fat.”
— Iris ShaiView source
Circulation
Harvard University
